Eli Casdin's most recent trade in Standard BioTools Inc was a trade of 125,660 Stock Option (Right to buy) done . Disclosure was reported to the exchange on June 20, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Standard BioTools Inc | Eli D. Casdin | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2025 | 125,660 | 125,660 | - | - | Stock Option (Right to buy) | |
| Standard BioTools Inc | Eli D. Casdin | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2025 | 94,592 | 2,901,062 (4%) | 0% | 0 | Common Stock | |
| GeneDx Holdings Corp - Ord... | Eli D. Casdin | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jun 2025 | 12,924 | 0 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Eli D. Casdin | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jun 2025 | 12,924 | 20,518 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Eli D. Casdin | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jun 2025 | 12,924 | 0 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Eli D. Casdin | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jun 2025 | 12,924 | 20,518 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Eli D. Casdin | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 3,576 | 3,576 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Eli D. Casdin | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 3,576 | 3,576 | - | - | Restricted Stock Unit | |
| Standard BioTools Inc | Eli D. Casdin | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jul 2024 | 1,588 | 2,752,332 (3%) | 0% | 0 | Common Stock | |
| Standard BioTools Inc | Eli D. Casdin | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2024 | 72,213 | 72,213 | - | - | Stock Option (Right to buy) | |
| Standard BioTools Inc | Eli D. Casdin | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2024 | 43,128 | 2,750,744 (3%) | 0% | 0 | Common Stock | |
| GeneDx Holdings Corp - Ord... | Eli D. Casdin | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2024 | 12,924 | 12,924 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Eli D. Casdin | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jun 2024 | 5,828 | 7,593 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Eli D. Casdin | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jun 2024 | 5,828 | 0 | - | - | Restricted Stock Unit | |
| Standard BioTools Inc | Casdin D. Eli | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 2.50 per share. | 20 Feb 2024 | 22,800 | 103,556 (0%) | 0% | 2.5 | 57,000 | Common Stock |
| Standard BioTools Inc | Eli Casdin D. | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 11,246,525 | 11,246,525 (15%) | 15% | - | Common Stock | |
| Standard BioTools Inc | Eli D. Casdin | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 7,548,000 | 7,548,000 (10%) | 10% | - | Common Stock | |
| Standard BioTools Inc | Casdin D. Eli | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 4,824,802 | 4,824,802 | - | - | Warrant to purchase common stock (Right to buy) | |
| Standard BioTools Inc | Casdin Eli D. | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 2,744,219 | 2,744,219 (3%) | 3% | - | Common Stock | |
| Standard BioTools Inc | D. Eli Casdin | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 51,842 | 51,842 | - | - | Stock Option (Right to buy) | |
| Standard BioTools Inc | Casdin D. Eli | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 46,514 | 46,514 | - | - | Stock Option (Right to buy) | |
| Standard BioTools Inc | Eli D. Casdin | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 22,866 | 22,866 | - | - | Stock Option (Right to buy) | |
| Standard BioTools Inc | Casdin Eli D. | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 22,866 | 22,866 | - | - | Stock Option (Right to buy) | |
| Standard BioTools Inc | Casdin D. Eli | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 3,807 | 80,756 (0%) | 0% | - | Common Stock | |
| Standard BioTools Inc | D. Eli Casdin | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 3,807 | 76,949 (0%) | 0% | - | Common Stock | |
| GeneDx Holdings Corp - Ord... | Eli D. Casdin | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2023 | 8,816 | 8,816 | - | - | Stock Option (Right to Buy) | |
| GeneDx Holdings Corp - Ord... | Eli D. Casdin | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2023 | 5,828 | 5,828 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Eli D. Casdin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 May 2023 | 45,454 | 58,290 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Eli D. Casdin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 May 2023 | 45,454 | 0 | - | - | Restricted Stock Unit | |
| SomaLogic Inc - Ordinary S... | Eli D. Casdin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2023 | 20,600 | 20,600 | - | - | Employee Stock Option (right to buy) | |
| SomaLogic Inc - Ordinary S... | Eli D. Casdin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2023 | 3,430 | 6,860 | - | 0 | Common Stock | |
| GeneDx Holdings Corp - Ord... | Eli D. Casdin | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.35 per share. | 31 Jan 2023 | 71,428,542 | 87,866,042 | - | 0.4 | 24,999,990 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Eli D. Casdin | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.35 per share. | 31 Jan 2023 | 14,285,743 | 14,285,743 | - | 0.3 | 5,000,010 | Class A Common Stock |
| EQRx Inc | Eli D. Casdin | Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2023 | 18,184 | 3,472,300 | - | - | Earn-out Shares | |
| EQRx Inc | Eli D. Casdin | Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2023 | 3,959 | 755,766 | - | - | Earn-out Shares | |
| EQRx Inc | Eli D. Casdin | Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2023 | 2,758 | 526,674 | - | - | Earn-out Shares | |
| EQRx Inc | Eli D. Casdin | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2022 | 101,010 | 101,010 | - | - | Stock Option (Right to Buy) | |
| SomaLogic Inc - Ordinary S... | Eli D. Casdin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Sep 2022 | 215,193 | 10,132,005 | - | - | Class A Common Stock | |
| Standard BioTools Inc | Eli D. Casdin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 42,571 | 42,571 | - | - | Stock Option (Right to Buy) | |
| Standard BioTools Inc | Eli D. Casdin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 30,914 | 46,766 (0%) | 0% | 0 | Common Stock | |
| Tenaya Therapeutics Inc | Eli D. Casdin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 39,727 | 39,727 | - | - | Stock Option (Right to buy) | |
| Century Therapeutics Inc | Eli D. Casdin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 19,872 | 19,872 | - | - | Stock Option (right to buy) | |
| Absci Corp | Eli D. Casdin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 28,700 | 28,700 | - | - | Stock Option (right to buy) | |
| GeneDx Holdings Corp - Ord... | Eli D. Casdin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2022 | 78,914 | 78,914 | - | - | Stock Option | |
| GeneDx Holdings Corp - Ord... | Eli D. Casdin | Director | Purchase of securities on an exchange or from another person at price $ 4.00 per share. | 29 Apr 2022 | 11,437,500 | 16,437,500 | - | 4 | 45,750,000 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Eli D. Casdin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Apr 2022 | 12,836 | 12,836 | - | - | Class A Common Stock | |
| GeneDx Holdings Corp - Ord... | Eli D. Casdin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Apr 2022 | 12,836 | 0 | - | - | Restricted Stock Unit | |
| Standard BioTools Inc | Eli D. Casdin | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2022 | 127,780 | 127,780 | - | - | Series B-1 Convertible Preferred Stock | |
| Standard BioTools Inc | Eli D. Casdin | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2022 | 23,401 | 23,401 | - | - | Stock Option (Right to Buy) | |
| Standard BioTools Inc | Eli D. Casdin | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2022 | 15,852 | 15,852 (0%) | 0% | 0 | Common Stock | |
| SomaLogic Inc - Ordinary S... | Eli D. Casdin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 20,600 | 20,600 | - | - | Employee Stock Option (right to buy) | |
| SomaLogic Inc - Ordinary S... | Eli D. Casdin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 3,430 | 3,430 | - | 0 | Common Stock | |
| EQRx Inc | Eli Casdin | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2021 | 25,214,934 | 25,214,934 | - | - | Common Stock | |
| EQRx Inc | Eli Casdin | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2021 | 8,659,372 | 8,659,372 | - | - | Class A Common Stock | |
| EQRx Inc | Eli Casdin | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 17 Dec 2021 | 8,659,372 | 0 | - | - | Class A Common Stock | |
| EQRx Inc | Eli Casdin | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 17 Dec 2021 | 8,659,372 | 8,659,372 | - | - | Common Stock | |
| EQRx Inc | Eli Casdin | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2021 | 8,659,372 | 0 | - | - | Class B Common Stock | |
| EQRx Inc | Eli Casdin | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2021 | 8,110,001 | 8,110,001 | - | - | Warrants to purchase Class A Common Stock (right to buy) | |
| EQRx Inc | Eli Casdin | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2021 | 5,488,164 | 5,488,164 | - | - | Common Stock | |
| EQRx Inc | Eli Casdin | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 10.00 per share. | 17 Dec 2021 | 5,000,000 | 30,214,934 | - | 10 | 50,000,000 | Common Stock |
| EQRx Inc | Eli Casdin | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 17 Dec 2021 | 4,840,628 | 8,659,372 | - | - | Class B Common Stock | |
| EQRx Inc | Eli Casdin | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2021 | 3,824,572 | 3,824,572 | - | - | Common Stock | |
| EQRx Inc | Eli Casdin | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2021 | 3,454,116 | 3,454,116 | - | - | Earn-out Shares | |
| EQRx Inc | Eli Casdin | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2021 | 751,807 | 751,807 | - | - | Earn-out Shares | |
| EQRx Inc | Eli Casdin | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2021 | 523,916 | 523,916 | - | - | Earn-out Shares | |
| SomaLogic Inc - Ordinary S... | Eli Casdin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2021 | 46,705 | 46,705 | - | - | Employee Stock Option (right to buy) | |
| GeneDx Holdings Corp - Ord... | Eli Casdin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2021 | 22,286 | 22,286 | - | - | Employee Stock Option (Right to Buy) | |
| GeneDx Holdings Corp - Ord... | Eli Casdin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2021 | 12,836 | 12,836 | - | - | Restricted Stock Unit | |
| Tenaya Therapeutics Inc | Eli Casdin | Director, Ten Percent Owner | 03 Aug 2021 | 2,374,849 | 2,374,849 | - | 0 | Common Stock | ||
| Tenaya Therapeutics Inc | Eli Casdin | Director, Ten Percent Owner | 03 Aug 2021 | 2,012,880 | 0 | - | - | Series B Preferred Stock | ||
| Tenaya Therapeutics Inc | Eli Casdin | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 15.00 per share. | 03 Aug 2021 | 850,000 | 3,224,849 | - | 15 | 12,750,000 | Common Stock |
| Tenaya Therapeutics Inc | Eli Casdin | Director, Ten Percent Owner | 03 Aug 2021 | 361,969 | 0 | - | - | Series C Preferred Stock | ||
| Tenaya Therapeutics Inc | Eli Casdin | Director, Ten Percent Owner | 03 Aug 2021 | 361,969 | 0 | - | - | Series C Preferred Stock | ||
| Tenaya Therapeutics Inc | Eli Casdin | Director, Ten Percent Owner | 03 Aug 2021 | 361,969 | 361,969 | - | 0 | Common Stock | ||
| Absci Corp | Eli Casdin | Director | 26 Jul 2021 | 4,209,573 | 4,209,573 | - | - | Common Stock | ||
| Absci Corp | Eli Casdin | Director | Purchase of securities on an exchange or from another person at price $ 16.00 per share. | 26 Jul 2021 | 1,562,500 | 6,745,333 | - | 16 | 25,000,000 | Common Stock |
| Absci Corp | Eli Casdin | Director | 26 Jul 2021 | 1,274,431 | 0 | - | - | Series E Preferred Stock | ||
| Absci Corp | Eli Casdin | Director | 26 Jul 2021 | 973,260 | 973,260 | - | - | Common Stock | ||
| Absci Corp | Eli Casdin | Director | 26 Jul 2021 | 973,260 | 5,182,833 | - | - | Common Stock | ||
| GeneDx Holdings Corp - Ord... | Eli Casdin | Director | 22 Jul 2021 | 10,993,750 | 10,993,750 | - | 0 | Class A Common Stock | ||
| GeneDx Holdings Corp - Ord... | Eli Casdin | Director | 22 Jul 2021 | 10,993,750 | 0 | - | - | Class B Common Stock | ||
| GeneDx Holdings Corp - Ord... | Eli Casdin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jul 2021 | 6,736,669 | 6,736,669 | - | - | Warrants to purchase Class A Common Stock (right to buy) | |
| GeneDx Holdings Corp - Ord... | Eli Casdin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jul 2021 | 5,000,000 | 5,000,000 | - | 0 | Class A Common Stock | |
| Century Therapeutics Inc | Eli Casdin | Director | 22 Jun 2021 | 6,180,500 | 0 | - | - | Series C Preferred Stock | ||
| Century Therapeutics Inc | Eli Casdin | Director | 22 Jun 2021 | 2,456,380 | 2,456,380 | - | - | Common Stock | ||
| Century Therapeutics Inc | Eli Casdin | Director | Purchase of securities on an exchange or from another person at price $ 20.00 per share. | 22 Jun 2021 | 750,000 | 3,206,380 | - | 20 | 15,000,000 | Common Stock |
| Century Therapeutics Inc | Eli Casdin | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 17 Jun 2021 | 39,744 | 39,744 | - | - | Option (right to buy) |